Who owns CYCLO THERAPEUTICS INC?
- Ticker: CYTH
- CUSIP Number: 23254x201
Tip: Access positions for across all investors
Analyze quarterly positions in Cyclo Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Cyclo Therapeutics stock
Who bought or sold CYCLO THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
EPIQ Capital Group | 739k | $583k | -10% | Sep 2024 |
|
Founders Fund V Management | 481k | $788k | 0% | Sep 2024 |
|
Vanguard Group | 447k | $567k | 13% | Jun 2024 |
|
Geode Capital Management | 152k | $120k | -13% | Sep 2024 |
|
Founders Fund VI Management | 110k | $180k | 0% | Sep 2024 |
|
BlackRock | 84k | $66k | 100% | Sep 2024 |
|
BlackRock | 60k | $76k | 60% | Jun 2024 |
|
State Street Corporation | 40k | $50k | 0% | Jun 2024 |
|
Northern Trust | 22k | $17k | 0% | Sep 2024 |
|
Wealth Enhancement Advisory Services | 20k | $26k | 0% | Jun 2024 |
|
Tower Research Capital | 5.0k | $6.3k | -24% | Jun 2024 |
|
Wells Fargo & Company | 4.4k | $3.5k | 0% | Sep 2024 |
|
Princeton Global Asset Management | 3.5k | $2.7k | -8% | Sep 2024 |
|
Morgan Stanley | 1.0k | $1.3k | -1% | Jun 2024 |
|
Bank of America Corporation | 994.00 | $786.949800 | 373% | Sep 2024 |
|
Royal Bank of Canada | 821.00 | $0 | 10% | Sep 2024 |
|
Jpmorgan Chase & Co | 194.00 | $153.415200 | 27% | Sep 2024 |
|
Steward Partners Investment Advisory | 90.00 | $114.003000 | 0% | Jun 2024 |
|
Advisor Group Holdings | 67.00 | $51.998700 | 0% | Sep 2024 |
|
Qube Research & Technologies | 21.00 | $26.999700 | 0% | Jun 2024 |
|
Who sold out of Cyclo Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Citadel Advisors | Jun 2024 | 25k | $31k |
Renaissance Technologies | Jun 2024 | 13k | $17k |